Experimental phase determination with selenomethionine or mercury-derivatization in serial femtosecond crystallography.
Experimental phase determination with selenomethionine or mercury-derivatization in serial femtosecond crystallography.
复制标题
DOI:
10.1107/s2052252517008557
复制
发表时间:
2017-09-01
期刊:
影响因子:
3.9
通讯作者:
Nakatsu T
中科院分区:
文献类型:
--
作者:
Yamashita K;Kuwabara N;Nakane T;Murai T;Mizohata E;Sugahara M;Pan D;Masuda T;Suzuki M;Sato T;Kodan A;Yamaguchi T;Nango E;Tanaka T;Tono K;Joti Y;Kameshima T;Hatsui T;Yabashi M;Manya H;Endo T;Kato R;Senda T;Kato H;Iwata S;Ago H;Yamamoto M;Yumoto F;Nakatsu T
High-energy X-rays are essential for de novo structure determination with strong anomalous scattering from selenium or mercury. Single-wavelength anomalous diffraction phasing using selenomethionine-derivatization and mercury-soaking techniques has been successfully applied to serial femtosecond crystallography with 13.0 keV or 12.6 keV X-rays produced at SACLA. Serial femtosecond crystallography (SFX) using X-ray free-electron lasers (XFELs) holds enormous potential for the structure determination of proteins for which it is difficult to produce large and high-quality crystals. SFX has been applied to various systems, but rarely to proteins that have previously unknown structures. Consequently, the majority of previously obtained SFX structures have been solved by the molecular replacement method. To facilitate protein structure determination by SFX, it is essential to establish phasing methods that work efficiently for SFX. Here, selenomethionine derivatization and mercury soaking have been investigated for SFX experiments using the high-energy XFEL at the SPring-8 Angstrom Compact Free-Electron Laser (SACLA), Hyogo, Japan. Three successful cases are reported of single-wavelength anomalous diffraction (SAD) phasing using X-rays of less than 1 Å wavelength with reasonable numbers of diffraction patterns (13 000, 60 000 and 11 000). It is demonstrated that the combination of high-energy X-rays from an XFEL and commonly used heavy-atom incorporation techniques will enable routine de novo structural determination of biomacromolecules.